193 related articles for article (PubMed ID: 22083803)
1. Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.
de Lau LM; Verbaan D; Marinus J; Heutink P; van Hilten JJ
Mov Disord; 2012 Jan; 27(1):132-5. PubMed ID: 22083803
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
[TBL] [Abstract][Full Text] [Related]
3. G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease.
Xie T; Ho SL; Li LS; Ma OC
Mov Disord; 1997 May; 12(3):426-7. PubMed ID: 9159741
[TBL] [Abstract][Full Text] [Related]
4. The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.
Suzuki M; Mamun MR; Hara K; Ozeki T; Yamada Y; Kadowaki T; Honda H; Yanagihara Y; Ito YM; Kameyama S; Ohta N; Hosoi T; Arai T; Sawabe M; Takeuchi T; Takahashi S; Kitamura T
Eur Urol; 2005 Nov; 48(5):752-9. PubMed ID: 16126332
[TBL] [Abstract][Full Text] [Related]
5. Association between Val158Met functional polymorphism in the COMT gene and risk of preeclampsia in a Chinese population.
Liang S; Liu X; Fan P; Liu R; Zhang J; He G; Liu Y; Bai H
Arch Med Res; 2012 Feb; 43(2):154-8. PubMed ID: 22475780
[TBL] [Abstract][Full Text] [Related]
6. Negative association between catechol-O-methyltransferase (COMT) gene Val158Met polymorphism and persistent tardive dyskinesia in schizophrenia.
Lai IC; Wang YC; Lin CC; Bai YM; Liao DL; Yu SC; Lin CY; Chen JY; Liou YJ
J Neural Transm (Vienna); 2005 Aug; 112(8):1107-13. PubMed ID: 15583953
[TBL] [Abstract][Full Text] [Related]
7. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
8. Catechol-O-methyltransferase gene Val108/158Met polymorphism, and susceptibility to schizophrenia: association is more significant in women.
Sazci A; Ergul E; Kucukali I; Kilic G; Kaya G; Kara I
Brain Res Mol Brain Res; 2004 Dec; 132(1):51-6. PubMed ID: 15548428
[TBL] [Abstract][Full Text] [Related]
9. COMT gene val158met polymorphism in patients with dyspeptic symptoms.
Tahara T; Arisawa T; Shibata T; Nakamura M; Wang F; Hirata I
Hepatogastroenterology; 2008; 55(84):979-82. PubMed ID: 18705311
[TBL] [Abstract][Full Text] [Related]
10. The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.
Rakvåg TT; Klepstad P; Baar C; Kvam TM; Dale O; Kaasa S; Krokan HE; Skorpen F
Pain; 2005 Jul; 116(1-2):73-8. PubMed ID: 15927391
[TBL] [Abstract][Full Text] [Related]
11. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.
Dwivedi A; Dwivedi N; Kumar A; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Mohanty S; Joshi D
J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):98-106. PubMed ID: 35603896
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.
Wu H; Dong F; Wang Y; Xiao Q; Yang Q; Zhao J; Quinn TJ; Chen SD; Liu J
Parkinsonism Relat Disord; 2014 Oct; 20(10):1094-6. PubMed ID: 25108642
[TBL] [Abstract][Full Text] [Related]
13. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
[TBL] [Abstract][Full Text] [Related]
14. The flexible mind is associated with the catechol-O-methyltransferase (COMT) Val158Met polymorphism: evidence for a role of dopamine in the control of task-switching.
Colzato LS; Waszak F; Nieuwenhuis S; Posthuma D; Hommel B
Neuropsychologia; 2010 Jul; 48(9):2764-8. PubMed ID: 20434465
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.
Contin M; Martinelli P; Mochi M; Riva R; Albani F; Baruzzi A
Mov Disord; 2005 Jun; 20(6):734-9. PubMed ID: 15747357
[TBL] [Abstract][Full Text] [Related]
16. Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease.
Liu J; Chen P; Guo M; Lu L; Li L
Neurol Sci; 2015 Apr; 36(4):621-3. PubMed ID: 25367407
[TBL] [Abstract][Full Text] [Related]
17. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.
Rothe C; Koszycki D; Bradwejn J; King N; Deluca V; Tharmalingam S; Macciardi F; Deckert J; Kennedy JL
Neuropsychopharmacology; 2006 Oct; 31(10):2237-42. PubMed ID: 16525418
[TBL] [Abstract][Full Text] [Related]
18. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.
Białecka M; Droździk M; Kłodowska-Duda G; Honczarenko K; Gawrońska-Szklarz B; Opala G; Stankiewicz J
Acta Neurol Scand; 2004 Oct; 110(4):260-6. PubMed ID: 15355491
[TBL] [Abstract][Full Text] [Related]
19. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-o-methyltransferase Val(158)Met polymorphism.
Kolassa IT; Kolassa S; Ertl V; Papassotiropoulos A; De Quervain DJ
Biol Psychiatry; 2010 Feb; 67(4):304-8. PubMed ID: 19944409
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1310-3. PubMed ID: 17217814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
